Fosamprenavir treatment in a highly active antiretroviral therapy schedule induces a HCV-RNA decrease and a Th1 network boost in HIV/HCV-coinfected patients

Author: Perrella A.   Sbreglia C.   D’Antonio A.   Atripaldi L.   Perrella O.  

Publisher: Blackwell Publishing

ISSN: 1198-743X

Source: Clinical Microbiology & Infection, Vol.16, Iss.6, 2010-06, pp. : 676-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content